Literature DB >> 12861075

The two faces of transforming growth factor beta in carcinogenesis.

Anita B Roberts1, Lalage M Wakefield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12861075      PMCID： PMC166359          DOI： 10.1073/pnas.1633291100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  34 in total

Review 1.  Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.

Authors:  S J Kim; Y H Im; S D Markowitz; Y J Bang
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

Review 2.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif.

Authors:  Rebecca A Randall; Stéphane Germain; Gareth J Inman; Paul A Bates; Caroline S Hill
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

Review 6.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

7.  Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.

Authors:  S J Santner; P J Dawson; L Tait; H D Soule; J Eliason; A N Mohamed; S R Wolman; G H Heppner; F R Miller
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

8.  Role of transforming growth factor-beta signaling in cancer.

Authors:  M P de Caestecker; E Piek; A B Roberts
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

9.  Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.

Authors:  H Gobbi; C L Arteaga; R A Jensen; J F Simpson; W D Dupont; S J Olson; P A Schuyler; W D Plummer; D L Page
Journal:  Histopathology       Date:  2000-02       Impact factor: 5.087

10.  Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells.

Authors:  M R Stampfer; J Garbe; G Levine; S Lichtsteiner; A P Vasserot; P Yaswen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205
View more
  291 in total

Review 1.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

Review 2.  Epigenetics of kidney cancer and bladder cancer.

Authors:  Amanda M Hoffman; Paul Cairns
Journal:  Epigenomics       Date:  2011-02       Impact factor: 4.778

3.  STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells.

Authors:  Carrie M Eggers; Erik R Kline; Diansheng Zhong; Wei Zhou; Adam I Marcus
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

4.  Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.

Authors:  Lei Quan; Zhihong Gong; Song Yao; Elisa V Bandera; Gary Zirpoli; Helena Hwang; Michelle Roberts; Gregory Ciupak; Warren Davis; Lara Sucheston; Karen Pawlish; Dana H Bovbjerg; Lina Jandorf; Citadel Cabasag; Jean-Gabriel Coignet; Christine B Ambrosone; Chi-Chen Hong
Journal:  Int J Cancer       Date:  2013-10-08       Impact factor: 7.396

Review 5.  Role of SMAD proteins in colitis-associated cancer: from known to the unknown.

Authors:  P Chandrasinghe; B Cereser; M Moorghen; I Al Bakir; N Tabassum; A Hart; J Stebbing; J Warusavitarne
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

6.  Thiazolidinediones as anti-cancer agents.

Authors:  Carmelo Blanquicett; Jesse Roman; C Michael Hart
Journal:  Cancer Ther       Date:  2008

7.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

8.  Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.

Authors:  Takanori Tsuji; Soichiro Ibaragi; Kaori Shima; Miaofen G Hu; Miki Katsurano; Akira Sasaki; Guo-fu Hu
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 9.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

10.  The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus.

Authors:  Franziska Pühringer-Oppermann; Mario Sarbia; Nicola Ott; Björn L D M Brücher
Journal:  Int J Colorectal Dis       Date:  2009-12-15       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.